BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8880004)

  • 1. Effects of altered prenatal hormonal environment on expression of autoimmune disease in NZB/NZW mice.
    Walker SE; Keisler LW; Caldwell CW; Kier AB; vom Saal FS
    Environ Health Perspect; 1996 Aug; 104 Suppl 4(Suppl 4):815-21. PubMed ID: 8880004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal manipulation of the prenatal environment alters reproductive morphology and increases longevity in autoimmune NZB/W mice.
    Keisler LW; Vom Saal FS; Keisler DH; Walker SE
    Biol Reprod; 1991 Apr; 44(4):707-16. PubMed ID: 2043742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant hormone balance in fetal autoimmune NZB/W mice following prenatal exposure to testosterone excess or the androgen blocker flutamide.
    Keisler LW; vom Saal FS; Keisler DH; Rudeen PK; Walker SE
    Biol Reprod; 1995 Nov; 53(5):1190-7. PubMed ID: 8527525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.
    Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T
    Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.
    Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD
    J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated deaths from systemic lupus erythematosus in NZB x NZW F1 mice treated with the testosterone-blocking drug flutamide.
    Walker SE; Besch-Williford CL; Keisler DH
    J Lab Clin Med; 1994 Sep; 124(3):401-7. PubMed ID: 8083583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
    Atencio S; Amano H; Izui S; Kotzin BL
    J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic epithelial cell abnormalities in (NZB x H-2u)F1 mice.
    Takeoka Y; Whitmer KJ; Chen SY; Ansari AA; Boyd RL; Shultz LD; Suehiro S; Gershwin ME
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):297-307. PubMed ID: 7554452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
    Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
    Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice.
    Sawai C; Anderson K; Walser-Kuntz D
    Environ Health Perspect; 2003 Dec; 111(16):1883-7. PubMed ID: 14644661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of NZB/NZW mice with total lymphoid irradiation: long-lasting suppression of disease without generalized immune suppression.
    Kotzin BL; Arndt R; Okada S; Ward R; Thach AB; Strober S
    J Immunol; 1986 May; 136(9):3259-65. PubMed ID: 2937842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant genetic control of invariant TCR-bearing NKT cell function in New Zealand mouse strains: possible involvement in systemic lupus erythematosus pathogenesis.
    Tsukamoto K; Ohtsuji M; Shiroiwa W; Lin Q; Nakamura K; Tsurui H; Jiang Y; Sudo K; Nishimura H; Shirai T; Hirose S
    J Immunol; 2008 Apr; 180(7):4530-9. PubMed ID: 18354175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
    Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
    Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.
    Reininger L; Radaszkiewicz T; Kosco M; Melchers F; Rolink AG
    J Exp Med; 1992 Nov; 176(5):1343-53. PubMed ID: 1402680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome.
    Vendramini AC; Soo C; Sullivan DA
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):3002-6. PubMed ID: 1917404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.